Our Technology
Home/Products/Immunofluorescence-Platform/COVID-19/Finecare™ 2019-nCoV RBD Test
Finecare™ 2019-nCoV RBD Test
RBD (receptor binding domain) of 2019-nCoV virus S1 protein is the region that binds to the ACE2 receptor on human cells as the first step of virus invading.
  • Performance Evaluation
  • INTENDED USE
    The Finecare™ 2019-nCoV RBD Antibody Test is a fluorescence immunoassay used along with Finecare™ FIA Meters for qualitative and semi-quantitative detection of spike receptor-binding domain (RBD) antibodies of novel coronaviruses (2019-nCoV) in human fingerstick whole blood, venipuncture whole blood, serum or plasma specimen.

    The 2019-nCoV RBD antibodies are protective antibody produced by the human body after inoculation with 2019-nCoV vaccine or infection with 2019-nCoV. The test is intended as an aid to assess the adaptive humoral immune response to the 2019-nCoV RBD protein.
  • STORAGE AND STABILITY
    1. Store at 4~30°C in the sealed pouch up to the expiration date printed on the package. Do not freeze.
    2. The test device should be used within 1 hour after taking out from the foil envelope.
    3. Keep away from sunlight, moisture and heat.
    4. Kit contents are stable until the expiration date printed on the outer box.
SPECIFICATION
Description
Cat. No. Sample Type Sample Volume Reaction Time Storage Temperature Shelf Life
W290 Fingerstick whole blood,
venipuncture whole blood,
serum or plasma
20 µL 15min 4~30℃ 24 months

Get Free Quote Now
If you’re interested in our products or service, please leave your information here, and we will be in touch with you shortly.
*
*
*
*
*
Submit
HOW CAN WE HELP?
Wondfo is committed to quality customer service. If you have any question, please feel free to contact us.
Request